Related Experiment Video
Updated: Sep 9, 2025
Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Mitophagy in kidney transplantation ischemia-reperfusion injury
Xingxia Wang1, Rumeng Li2, Bocheng Zhu1
1Department of Nephrology, No. 903 Hospital of PLA Joint Logistics Support Force, Hangzhou, 310003, China.
Abstract:
Renal ischemia-reperfusion injury (IRI) remains a major challenge impacting graft survival following transplantation. During the ischemic phase, mitochondrial dysfunction leads to adenosine triphosphate (ATP) depletion and calcium overload. Upon reperfusion, reactive oxygen species (ROS) are generated, exacerbating mitochondrial damage and triggering inflammatory responses. This process is associated not only with delayed graft function (DGF) but also with allograft dysfunction. Mitochondria, serving as the high-energy-demand hub of the kidney, require precise regulation of their dynamic balance and mitophagy. Mitophagy selectively removes damaged mitochondria to maintain cellular homeostasis. In the context of IRI, mitophagy exhibits a bidirectional regulatory role: moderate activation can improve energy metabolism, whereas excessive or insufficient activation may exacerbate renal injury. To provide new insights for enhancing graft survival rates, this paper examines the molecular mechanisms, therapeutic targets, and dual regulatory roles involved.
Insights
Renal ischemia-reperfusion injury (IRI) impacts kidney transplant survival. Mitophagy, the process of removing damaged mitochondria, plays a complex, dual role in IRI, offering potential therapeutic targets for improving graft outcomes.
Area of Science:
- Nephrology
- Transplantation immunology
- Mitochondrial biology
Background:
- Renal ischemia-reperfusion injury (IRI) is a significant barrier to successful kidney transplantation.
- Mitochondrial dysfunction, characterized by ATP depletion and calcium overload, is central to IRI pathogenesis.
- Reactive oxygen species (ROS) generated during reperfusion further damage mitochondria and promote inflammation, contributing to delayed graft function and allograft dysfunction.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying renal IRI.
- To identify potential therapeutic targets for mitigating IRI.
- To examine the bidirectional regulatory role of mitophagy in renal IRI.
Main Methods:
- Review of molecular mechanisms of renal IRI.
- Analysis of the role of mitochondrial dynamics and mitophagy in IRI.
- Exploration of therapeutic strategies targeting mitophagy.
Main Results:
- Mitochondrial dysfunction and ROS generation are key events in IRI.
- Mitophagy plays a dual role in IRI: moderate activation is protective, while excessive or insufficient mitophagy is detrimental.
- Dysregulation of mitophagy contributes to delayed graft function and allograft dysfunction.
Conclusions:
- Understanding the complex role of mitophagy in renal IRI is crucial for developing effective therapies.
- Targeting mitophagy presents a promising strategy to enhance kidney graft survival and function.
- Further research into the precise regulation of mitophagy in IRI could lead to improved clinical outcomes in kidney transplantation.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:26Kidney Transplant II: Surgical Procedure